NMPA Approval

Trimetazidine Hydrochloride Tablets

Approval Number

国药准字H20083596

Company武汉海特生物制药股份有限公司

Registration Date

December 20, 2022

Previous Approval Numbers

国药准字H20083596

Drug Information

Generic Name

盐酸曲美他嗪片

Brand Name

幸孚

Dosage Form

片剂

Strength

20mg

Drug Type

化学药品

Registration Date

December 20, 2022

Company Information

Applicant Company

Company Name武汉海特生物制药股份有限公司

Company Address

武汉经济技术开发区海特科技园

Manufacturing Company

Company Name湖北四环制药有限公司

Company Address

湖北省武汉市经济技术开发区绿岛科技园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸曲美他嗪片 - NMPA 批准文号 | MedPath